{"id":"W4360992178","doi":"10.1159/000530364","title":"Maximal Extension Interval and Visual Outcomes in a Treat-and-Extend Protocol: A Post Hoc Analysis of the CANTREAT Randomized Trial","year":2023,"lang":"en","type":"article","venue":"Ophthalmologica","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Novartis (Canada); Sunnybrook Health Science Centre; Western University; University of Toronto","funders":"Novartis Pharmaceuticals Canada","keywords":"Ranibizumab; Post-hoc analysis; Medicine; Visual acuity; Regimen; Macular degeneration; Randomized controlled trial; Ophthalmology; Post hoc; Confidence interval; Cohort; Surgery; Internal medicine; Bevacizumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02336876,0.002773956,0.005352138,0.0006074929,0.001100427,0.0020874,0.001280181,0.002180179,0.01441917],"category_scores_gemma":[0.02523389,0.0008583173,0.004531156,0.0008246684,0.001721531,0.001633206,0.001000277,0.003808329,0.001271777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00248094,"about_ca_system_score_gemma":0.006178802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002906077,"about_ca_topic_score_gemma":0.005359312,"domain_scores_codex":[0.9825369,0.01275432,0.0009097111,0.001463006,0.001150466,0.00118561],"domain_scores_gemma":[0.9846687,0.007007394,0.00352103,0.002106664,0.001746499,0.0009497714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9911923,0.001204644,0.0004550888,0.0004709395,0.00157105,0.000018535,0.00004678262,0.0003623121,0.0002322894,0.0002440199,0.001791309,0.002410687],"study_design_scores_gemma":[0.9503828,0.03622482,0.004417014,0.0001610004,0.002539127,0.0000188028,0.00004211221,0.001627446,0.0003789634,0.0009228372,0.003232683,0.00005236018],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6914033,0.006149919,0.010765,0.002886344,0.003715402,0.2489845,0.01515626,0.001107723,0.0198316],"genre_scores_gemma":[0.5788253,0.0008480826,0.01201921,0.00215692,0.0009172755,0.3921553,0.005296919,0.0001855816,0.007595424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02336876,"threshold_uncertainty_score":0.1235873,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03151313236478832,"score_gpt":0.3711518859570248,"score_spread":0.3396387535922364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}